TY - JOUR T1 - PRELIMINARY RESULTS OF DARATUMUMAB, CYCLOPHOSPHAMIDE, THALIDOMIDE AND DEXAMETHASONE: A QUADRUPLET INTENSIED TREATMENT FOR NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) TRANSPLANT ELIGIBLE (TE) PATIENTS JO - Hematology, Transfusion and Cell Therapy T2 - AU - CrusoƩ,E.Q. AU - Salvino,M.A. AU - Santos,H.H.M. AU - Santos,A.S. AU - Almeida,A.M. AU - Fonseca,C.A. AU - Leal,J.S. AU - Santos,J.A. AU - Hungria,V.T.M. AU - Arruda,M.G.B. SN - 25311379 M3 - 10.1016/j.htct.2020.10.456 DO - 10.1016/j.htct.2020.10.456 UR - http://www.htct.com.br/en-preliminary-results-of-daratumumab-cyclophosphamide-articulo-S2531137920307422 ER -